Physician profile
Subashini Narayanan
NPI 1710986864
$3,506.84
in general payments reported to CMS, 2019-2025
32 companies · $650 in 2025
The $650 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $890 · 2020: $100 · 2021: $100 · 2022: $608 · 2023: $602 · 2024: $556 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,808.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $522.29 | 2019-2024 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $386.95 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Abbott Laboratories | $367.47 | 2019-2025 | Freestyle Libre 3, Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $363.16 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $268.56 | 2019-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $212.03 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $203.18 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $135.95 | 2019-2020 | |
| Boston Scientific Corporation | $112.02 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Smith+Nephew, INC. | $107.49 | 2023 | Real Intelligence |
| Optinose US, INC. | $75.94 | 2019 | |
| Sanofi-Aventis U.S. LLC | $73.06 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $65.09 | 2022 | |
| Allergan, INC. | $63.66 | 2019-2022 | |
| Dexcom, INC. | $60.34 | 2024-2025 | Dexcom G6 Transmitter |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $50.51 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.87 | 2025 | |
| Medtronic, INC. | $39.82 | 2022-2025 | Inceptiv |
| Astellas Pharma US INC | $35.89 | 2025 | Veozah |
| Exact Sciences Corporation | $35.81 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amgen INC. | $35.79 | 2019-2024 | Evenity, Prolia |
| Neurocrine Biosciences, INC. | $34.54 | 2025 | |
| Seqirus USA INC | $33.43 | 2024-2025 | Flucelvax, Fluad |
| Vbi Vaccine (Delaware) INC. | $31.87 | 2022-2023 | Prehevbrio |
| Janssen Pharmaceuticals, INC | $24.02 | 2019 | |
| Inogen, INC. | $22.94 | 2025 | |
| Gilead Sciences, INC. | $21.09 | 2024 | |
| Biotronik Nro, INC. | $20.78 | 2025 | Prospera |
| Idorsia Pharmaceuticals US INC | $17.49 | 2023 | Quviviq |
| Genentech USA, INC. | $15.53 | 2019 | |
| Insulet Corporation | $13.12 | 2022 | |
| Amarin Pharma, INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subashini Narayanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.